Efficacy Of Web-based Breastfeeding Education
Launched by NURDAN DEMIRCI · May 30, 2024
Trial Information
Current as of February 08, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Breastfeeding is the safest and healthiest method of feeding an infant and positively affects the health of both the mother and the baby in the short and long term. Breast milk not only meets the nutritional needs of the newborn, but also protects it from many diseases, makes a great contribution to its mental and physical development, and most importantly, it provides a unique bond between mother and baby.
According to TDHS 2018 data, the rate of exclusive breastfeeding for the first six months is 41%, and this rate decreases with age. The rate of breastfeeding for 0-1-month-old children ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Volunteering to participate in the study.
- • 2. Being primiparous at 24-36 weeks of pregnancy.
- • 3. To be able to speak and speak Turkish.
- • 4. To be at least a primary school graduate.
- • 5. Having a computer or smartphone at home and being able to use it.
- • 6. No risk in pregnancy.
- • 7. The woman does not have any chronic disease.
- Exclusion Criteria:
- • 1. The emergence of a risky situation during pregnancy.
- • 2. Premature birth of the woman participating in the study.
- • 3. Carrying out a risky birth and hospitalization of the mother or baby due to it.
- • 4. Termination of pregnancy prematurely for any reason (such as infant death)
- • 5. The fact that the pregnant women in the experimental group did not complete the training modules before birth.
- • 6. The fact that the women participating in the study did not respond to the directed scales and questionnaires.
- • 7. The woman's desire to quit working without giving any reason.
Trial Officials
Elif velioğlu, PhDc
Principal Investigator
Marmara University
Nurdan Demirci, Prof
Study Director
Marmara University
About Nurdan Demirci
Nurdan Demirci is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative study designs and rigorous methodologies. With a focus on ethical practices and regulatory compliance, Nurdan Demirci collaborates with leading researchers and institutions to facilitate the development of groundbreaking therapies. The organization prioritizes patient safety and engagement, ensuring that clinical trials are conducted with the highest standards of integrity and transparency. By fostering a culture of scientific excellence, Nurdan Demirci aims to contribute significantly to the healthcare landscape and address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0